- 2024 - 2028 透析患者に発生する腎細胞癌のOmics解析と腫瘍免疫微小環境の統合的理解
- 2024 - 2028 泌尿器がんのクローン進化と腫瘍間質の空間解析による免疫治療耐性メカニズムの解明
- 2022 - 2025 尿路上皮がんにおけるAXL/GAS6発現と腫瘍免疫微小環境の統合的理解
- 2022 - 2025 In situな尿路上皮がん免疫ゲノミクス多様性解析とリキッドバイオプシーの確立
- 2021 - 2024 腎癌におけるlong non-coding RNAの臨床的意義の解明
- 2021 - 2024 新規3次元イメージングによる腎がん微小脈管の異質性解析
- 2020 - 2023 Integrated analysis of ITH in drug resistant prostate cancer by single cell analysis
- 2020 - 2023 Single-cell RNA-seq reveals details of BCG-refractory bladder cancer
- 2019 - 2022 Targeting cancer stem cells and spatial niches in kidney cancer: Unravelling intratumoral heterogeneity
- 2019 - 2022 Targeting cancer stem cells and spatial niches in kidney cancer: Unravelling intratumoral heterogeneity
- 2019 - 2022 全国がん登録の利活用に向けた学会研究体制の整備とその試行、 臨床データベースに基づく臨床研究の推進、及び国民への研究情報提供の在り方に関する研究
- 2018 - 2021 Development of novel therapeutic modality by integrated analysis of immune environment of renal cell carcinoma and remodeling after inhibition of angiogenesis
- 2018 - 2021 膀胱尿管逆流に対するカラードプラ法超音波検査を用いた新たな非侵襲的診断法の確立
- 2018 - 2021 腎細胞癌の免疫環境と血管新生阻害後のリモデリングの統合的解析による新規治療の開発
- 2018 - 2021 膀胱尿管逆流に対するカラードプラ法超音波検査を用いた新たな非侵襲的診断法の確立
- 2017 - 2020 Utility of liquid biopsy for metastatic renal cell carcinoma
- 2018 - 2020 シングルセルレベルの腫瘍内不均一性をターゲットとする革新的な創薬研究
- 2017 - 2020 Utility of liquid biopsy for metastatic renal cell carcinoma
- 2015 - 2019 Evaluation of the usefulness of contrast-enhanced ultrasonography for renal masses: Aiming at overcoming the problem of conventional diagnostic modalities
- 2018 - 2019 去勢抵抗性前立腺がん(CRPC)に有効な薬剤の開発
- 2015 - 2018 Elucidation of refractory mechanism to the molecular targeted therapy for renal cell carcinoma
- 2015 - 2018 Elucidation of refractory mechanism to the molecular targeted therapy for renal cell carcinoma
- 2015 - 2017 The new strategy for urothelial carcinoma by inhibiting autophagy
- 2015 - 2017 Antitumor effect by regulation of EZH2 on urothelial carcinoma
- 2014 - 2017 Tumor microenvironment and ubiquitin system in platinum resistance urothelial carcinoma
- 2014 - 2017 New treatment strategy with mesenchymal stem cells for obstructive uropathy
- 2016 - 2017 東日本におけるiPS細胞等臨床研究推進モデル病院の構築
- 2014 - 2017 間葉系幹細胞を用いた閉塞性尿路疾患に対する新規治療方法の確立
- 2014 - 2017 尿路上皮癌における抗がん剤耐性獲得下の微小環境とユビキチンシステムの解明
- 2012 - 2017 標準的治療の確立が望まれる難治性疾患に対する新規治療法の開発
- 2014 - 2016 Elucidation of development mechanism in renal cell carcinoma: focus on fatty acid receptor and visceral fat.
- 2013 - 2015 進行性透析腎癌のmTOR阻害薬抵抗性の克服に向けた基礎研究
- 2013 - 2015 New treatment strategy of refractory prostate cancer by regulation of androgen-androgen receptor axis and PI3K/Akt pathway
- 2013 - 2015 NVP-BEZ235 Therapy for Bladder Cancer and Prevention of Tumor Invasion and Metastasis
- 2012 - 2015 Elucidation of molecular targets based on epithelial-mesenchymal transition for the treatment of renal cell carcinoma
- 2012 - 2015 Resistance to mTOR inhibitor in metastatic dialysis-related renal cell carcinoma
- 2013 - 2015 腎細胞癌における上皮間葉転換に着目した新規標的分子の探索
- 2013 - 2014 骨髄由来間葉系幹細胞を用いた閉塞性腎症に対する新規治療方法の確立
- 2013 - 2014 転写因子を制御した新規尿路上皮癌治療戦略の確立
- 2010 - 2013 高悪性度筋層非浸潤癌に対する経尿道的膀胱腫瘍切除後の治療方針確立に関する研究
- 2011 - 2013 Establishment of the novel treatment strategy against urothelial carcinoma controlling for the transcription factors
- 2011 - 2013 New treatment strategy with bone marrow-derived mesenchymal stem cells for obstructive nephropathy
- 2011 - 2012 Liposomal PTEN Gene Therapy in an Orthotopic Bladder Cancer Modeland Prevention of Tumor Invasion and Metastasis
- 2011 - 2012 Liposomal IL-21/IL-15 Gene Therapy in an Orthotopic Bladder Cancer Model and Prevention of Tumor Invasion and Metastasis
- 2010 - 2012 Functional analysis of miRNAs in microenvironment of CRPC.
- 2009 - 2011 Microenviroment and organ specific metastases in urological cancers as tools to elucidate molecular mechanism of carcinogenesis and tumor development.
- 2008 - 2010 The chemotherapeutic strategy with a novel NF-kappa B inhibitor in bladder cancer
- 2007 - 2008 Mechanism of renal cell carcinoma carcinogenesis arising in the acquired cystic kidney disease
- 2007 - 2008 Global survey on clinical research supporting and promoting system, aiming Japanese clinical research improvement.
- 2005 - 2006 Hypoxia responsiveness in renal cell carcinoma
- 2004 - 2006 Pathophysiological role of NF k B and the efficacy of a novel NF K B inhibitor in urological cancers
- 2004 - 2005 Gene therapy for hormone-refractory prostate cancer targeting androgen receptor
- 2003 - 2004 Role of cytokine-inducible transcription factors in renal cell carcinoma
- 2002 - 2004 Elucidation of pathophysiological significance of LIF and development of new treatment strategy in prostate cancer
- 2001 - 2003 Establishment of gene therapy targeting bcl-2 and NF κB for urological malignancies
- 2001 - 2003 Establishment of a novel mouse model for studying prostate cancer metastasis to human bone and new therapeutic strategies.
- 2000 - 2001 Genetic analysis of multiple sproradic renal call carcinoma
- 1999 - 2001 Tumor Specific Gene Therapy Using Mutant Herpes Simplex Virus for Bladder Cancer
- 1998 - 2001 Pathophysiological role of IL-6 and IL-8 in the progression of prostate cancer and cachexia
- 1999 - 2000 腎細胞癌におけるホルモン依存性増殖の解明と治療への応用
- 1997 - 1999 Expression of cell adhesion molecules E-, P-, N-cadherin-6, -11, and -13 in renal cell carcinomas. An immunohistochemical study
- 1995 - 1997 Establish mentofthe minimally invasive treatments based on biological characteristics for advanceduro logical cancers.
- 1993 - 1993 腎細胞癌に対するIL-2封入リポソームを用いた局所動注療法の有用性の検討
- 1992 - 1992 腎細胞癌に対するIL-2封入リポソームの抗腫瘍効果の動物モデルを用いた検討
Show all
American Society of Clinical Oncology (ASCO)
, European Association of Urology (EAU)
, American Urological Association (AUA)
, 日本ヒト細胞学会
, 日本泌尿器腫瘍学会
, 日本生殖医学会
, 日本臨床腎移植学会
, 日本移植学会
, 日本内分泌外科学会
, 日本抗加齢医学会
, 日本老年泌尿器科学会
, 日本小児泌尿器科学会
, 日本排尿機能学会
, 日本がん分子標的治療学会
, 日本アンドロロジー学会
, 日本画像医学会
, 日本性機能学会
, 日本内視鏡外科学会
, 日本泌尿器内視鏡学会
, 日本癌治療学会
, 日本癌学会
, 日本透析医学会
, 日本腎臓学会
, 日本泌尿器科学会